{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:47:38Z","timestamp":1773240458342,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.cll.2004.05.009","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T17:01:38Z","timestamp":1113411698000},"page":"797-823","source":"Crossref","is-referenced-by-count":21,"title":["Emerging infections in transfusion medicine"],"prefix":"10.1016","volume":"24","author":[{"given":"Eberhard W.","family":"Fiebig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB1","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1537-2995.2001.41081069.x","article-title":"Syphilis, a disease of direct transfusion","volume":"41","author":"Schmidt","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2004.05.009_BIB2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.1943.02840170016005","article-title":"Jaundice occurring one to four months after transfusion of blood or plasma","volume":"121","author":"Beeson","year":"1943","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1537-2995.2002.00200.x","article-title":"International application of the incidence rate\/window period model","volume":"42","author":"Glynn","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2004.05.009_BIB5","series-title":"Rossi's principles of transfusion medicine","first-page":"718","article-title":"Transfusion-transmitted hepatitis C and non-A, non-B, non-C virus infections","author":"Alter","year":"2002"},{"key":"10.1016\/j.cll.2004.05.009_BIB6","series-title":"Blood banking and transfusion medicine","first-page":"431","article-title":"Hepatitis A, hepatitis B, and non-A, non-B, non-C viruses","author":"Dodd","year":"2003"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/315701","article-title":"Duration of viremia in hepatitis A virus infection","volume":"182","author":"Bower","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.0042-9007.2004.00377.x","article-title":"Transfusion of plasma from a blood donor induced hepatitis E in Rhesus monkey","volume":"86","author":"Xia","year":"2004","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1423-0410.1999.7620078.x","article-title":"Hepatitis E virus: relevance in blood donors and risk groups","volume":"76","author":"Mateos","year":"1999","journal-title":"Vox Sang"},{"issue":"4","key":"10.1016\/j.cll.2004.05.009_BIB10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1537-2995.2003.00342.x","article-title":"Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation","volume":"43","author":"Diwan","year":"2003","journal-title":"Transfusion"},{"issue":"17","key":"10.1016\/j.cll.2004.05.009_BIB11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/jama.1983.03340170039025","article-title":"Posttransfusion hepatitis type A","volume":"250","author":"Hollinger","year":"1983","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1998.38698326337.x","article-title":"Hepatitis A virus infections associated with clotting factor concentrate in the United States","volume":"38","author":"Soucie","year":"1998","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<91::AID-JMV1>3.0.CO;2-L","article-title":"A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool","volume":"57","author":"Chudy","year":"1999","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.cll.2004.05.009_BIB14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/514078","article-title":"Persistence and clinical significance of hepatitis G virus infections in injecting drug users","volume":"176","author":"Thomas","year":"1997","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/JCM.35.3.767-768.1997","article-title":"Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission","volume":"35","author":"Feucht","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.cll.2004.05.009_BIB17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa030107","article-title":"Persistent GB virus C infection and survival in HIV-infected men","volume":"350","author":"Williams","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cll.2004.05.009_BIB18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/jhep.2001.24268","article-title":"SEN virus infection and its relationship to transfusion-associated hepatitis","volume":"33","author":"Umemura","year":"2001","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cll.2004.05.009_BIB19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/379216","article-title":"Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A\u2013E hepatitis","volume":"188","author":"Umemura","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/tmrv.1997.0110155","article-title":"The incidence\/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection","volume":"11","author":"Kleinman","year":"1997","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1473-3099(03)00484-5","article-title":"Travel and the spread of HIV-1 genetic variants","volume":"3","author":"Perrin","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.cll.2004.05.009_BIB22","doi-asserted-by":"crossref","first-page":"F57","DOI":"10.1097\/00002030-199612000-00002","article-title":"Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions","volume":"10","author":"Apetrei","year":"1996","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.cll.2004.05.009_BIB23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1537-2995.2000.40111399.x","article-title":"Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply","volume":"40","author":"de Oliveira","year":"2000","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/tmrv.1997.0110173","article-title":"The clinical relevance of HTLV type I and II in transfusion medicine","volume":"11","author":"Vrielink","year":"1997","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/tmrv.2001.19946","article-title":"Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction","volume":"15","author":"Blajchman","year":"2001","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1537-2995.2003.00272.x","article-title":"Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors","volume":"43","author":"Hudnall","year":"2003","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.cll.2004.05.009_BIB27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1046\/j.1537-2995.2003.00490.x","article-title":"Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors","volume":"43","author":"Pellett","year":"2003","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.cll.2004.05.009_BIB28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1537-2995.2001.41091120.x","article-title":"Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses","volume":"41","author":"Challine","year":"2001","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nm0896-918","article-title":"The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma\u2013associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission","volume":"2","author":"Kedes","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1537-2995.1998.38898375517.x","article-title":"High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8","volume":"38","author":"Belec","year":"1998","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jmv.10183","article-title":"Detection of human herpesvirus 8 DNA in serum from blood donors with HHV-8 antibodies indicates possible bloodborne virus transmission","volume":"68","author":"Enbom","year":"2002","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0887-7963(99)80033-9","article-title":"The transfusion-associated transmission of parvovirus B19","volume":"13","author":"Azzi","year":"1999","journal-title":"Transfus Med Rev"},{"issue":"9","key":"10.1016\/j.cll.2004.05.009_BIB34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1701-2163(16)30329-2","article-title":"Parvovirus B19 infection in pregnancy","volume":"24","author":"Crane","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1537-2995.2001.41010130.x","article-title":"Parvovirus B19: implications for transfusion medicine. Summary of a workshop","volume":"41","author":"Brown","year":"2001","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.cll.2004.05.009_BIB36","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1046\/j.1537-2995.2000.40101203.x","article-title":"Clinical illness due to parvovirus B19 infection after infusion of solvent\/detergent-treated pooled plasma","volume":"40","author":"Koenigbauer","year":"2000","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1537-2995.1996.36396182142.x","article-title":"Parvovirus B19 infection in patients with hemophilia","volume":"36","author":"Ragni","year":"1996","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1046\/j.1537-2995.2002.00158.x","article-title":"Inactivation of parvovirus B19 during pasteurization of human serum albumin","volume":"42","author":"Blumel","year":"2002","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.cll.2004.05.009_BIB39","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1046\/j.1537-2995.2001.41121500.x","article-title":"High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation","volume":"41","author":"Weimer","year":"2001","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1537-2995.2002.00145.x","article-title":"Removal of neutralized model parvoviruses and enteroviruses in human IgG solutions by nanofiltration","volume":"42","author":"Omar","year":"2002","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2003.09.011","article-title":"Severe acute respiratory syndrome (SARS)\u2014paradigm of an emerging viral infection","volume":"29","author":"Berger","year":"2004","journal-title":"J Clin Virol"},{"issue":"27","key":"10.1016\/j.cll.2004.05.009_BIB42","first-page":"642","article-title":"Update: multistate outbreak of monkeypox\u2014Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.cll.2004.05.009_BIB43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam","volume":"350","author":"Tran","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/JCM.42.1.347-350.2004","article-title":"Detection of severe acute respiratory syndrome coronavirus in blood of infected patients","volume":"42","author":"Ng","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.cll.2004.05.009_BIB45","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJMp048039","article-title":"Crossing the species barrier\u2014one small step to man, one giant leap to mankind","volume":"350","author":"Klempner","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1537-2995.2003.00463.x","article-title":"Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors","volume":"43","author":"Welch","year":"2003","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-137-3-200208060-00009","article-title":"West Nile virus: a primer for the clinician","volume":"137","author":"Petersen","year":"2002","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.cll.2004.05.009_BIB48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1537-2995.2002.00167.x","article-title":"Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City","volume":"42","author":"Biggerstaff","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2004.05.009_BIB49","unstructured":"Centers for Disease Control and Prevention. West Nile virus 2002 case count. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile\/surv&controlCaseCount02.htm. Accessed April 6, 2004."},{"key":"10.1016\/j.cll.2004.05.009_BIB50","unstructured":"US Department of Health and Human Services. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER). Revised recommendations for the assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile Virus infection. Available at: http:\/\/www.fda.gov\/cber\/gdlns\/wnvguid.htm. Accessed April 6, 2004."},{"issue":"22","key":"10.1016\/j.cll.2004.05.009_BIB51","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.cll.2004.05.009_BIB52","first-page":"281","article-title":"Update: West Nile virus screening of blood donations and transfusion-associated transmission\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cll.2004.05.009_BIB53","unstructured":"Centers for Disease Control and Prevention. Division of Vector-Borne Infectious Diseases. Arboviral encephalitides. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/arbor\/index.htm. Accessed April 6, 2004."},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB54","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1537-2995.2003.030342.x","article-title":"Bacterial contamination of blood: lessons from the past and road map for the future","volume":"44","author":"Yomtovian","year":"2004","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1473-0502(01)00067-2","article-title":"Current status of bacterial contamination of autologous blood for transfusion","volume":"24","author":"Sugai","year":"2001","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.cll.2004.05.009_BIB56","series-title":"Transfusion reactions","first-page":"261","article-title":"Adverse consequences of autologous transfusion practice","author":"Yomtovian","year":"2001"},{"issue":"11","key":"10.1016\/j.cll.2004.05.009_BIB57","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1046\/j.1537-2995.2001.41111331.x","article-title":"Don't bug me: the problem of bacterial contamination of blood components\u2014challenges and solutions","volume":"41","author":"Jacobs","year":"2001","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.cll.2004.05.009_BIB58","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1537-2995.2001.41121493.x","article-title":"Transfusion-transmitted bacterial infection in the United States, 1998 through 2000","volume":"41","author":"Kuehnert","year":"2001","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1537-2995.2002.00122.x","article-title":"Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components","volume":"42","author":"Brecher","year":"2002","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.cll.2004.05.009_BIB60","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1537-2995.1993.331194082380.x","article-title":"A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets","volume":"33","author":"Yomtovian","year":"1993","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1537-2995.2004.44301.x","article-title":"An incremental solution to bacterial contamination: taking the first step","volume":"44","author":"Ness","year":"2004","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1537-2995.2001.41010074.x","article-title":"Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations","volume":"41","author":"Bruneau","year":"2001","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1423-0410.2001.00029.x","article-title":"Evaluation of donor arm disinfection techniques","volume":"80","author":"McDonald","year":"2001","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB64","first-page":"121","article-title":"Improving platelet safety: bacterial contamination of platelets","volume":"3","author":"Brecher","year":"2004","journal-title":"Curr Hematol Rep"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1086\/319347","article-title":"Ticks and tickborne bacterial diseases in humans: an emerging infectious threat","volume":"32","author":"Parola","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.cll.2004.05.009_BIB66","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3201\/eid0505.990504","article-title":"The human ehrlichioses in the United States","volume":"5","author":"McQuiston","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00062752-200311000-00002","article-title":"Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases","volume":"10","author":"Cable","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cll.2004.05.009_BIB68","unstructured":"Centers for Disease Control and Prevention. Division of Vector-Borne Infectious Diseases. CDC Lyme disease home page. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/lyme\/index.htm. Accessed April 28, 2004."},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB69","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/infdis\/170.1.231","article-title":"The risk of acquiring Lyme disease or babesiosis from a blood transfusion","volume":"170","author":"Gerber","year":"1994","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1537-2995.2000.40030290.x","article-title":"Reducing the risk of transfusion-transmitted rickettsial disease by WBC filtration, using Orientia tsutsugamushiin: a model system","volume":"40","author":"Mettille","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2004.05.009_BIB71","series-title":"Rossi's principles of transfusion medicine","first-page":"774","article-title":"Transmission of parasitic infections by blood transfusion","author":"Shulman","year":"2002"},{"key":"10.1016\/j.cll.2004.05.009_BIB72","unstructured":"Mollison P, Engelfriet C, Contreras M. Infectious agents transmitted by transfusion. In: Blood transfusion in clinical medicine. 9th edition. Oxford, UK: Blackwell Scientific Publications; 1993. p. 710\u201385."},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/tm.2000.7396","article-title":"Transfusion medicine in developing countries","volume":"14","author":"Sibinga","year":"2000","journal-title":"Transfus Med Rev"},{"issue":"26","key":"10.1016\/j.cll.2004.05.009_BIB74","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJM200106283442603","article-title":"Transfusion-transmitted malaria in the United States from 1963 through 1999","volume":"344","author":"Mungai","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cll.2004.05.009_BIB75","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V89.9.3077","article-title":"From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen","volume":"89","author":"Hadley","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1537-2995.2002.00050.x","article-title":"Potential value of Plasmodium falciparum-associated antigen and antibody detection for screening of blood donors to prevent transfusion-transmitted malaria","volume":"42","author":"Silvie","year":"2002","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1537-2995.2004.00644.x","article-title":"The cost-effectiveness of screening blood donors for malaria by PCR","volume":"44","author":"Shehata","year":"2004","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0025-7125(03)00092-0","article-title":"Babesiosis","volume":"86","author":"Krause","year":"2002","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3201\/eid0902.020271","article-title":"Endemic babesiosis in another Eastern state. New Jersey","volume":"9","author":"Herwaldt","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.cll.2004.05.009_BIB80","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199502023320504","article-title":"Infection with a babesia-like organism in northern California","volume":"332","author":"Persing","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3201\/eid0901.020149","article-title":"Transfusion-associated babesiosis after heart transplant","volume":"9","author":"Lux","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/tmrv.2002.31462","article-title":"The impact of babesiosis on transfusion medicine","volume":"16","author":"Pantanowitz","year":"2002","journal-title":"Transfus Med Rev"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0887-7963(96)80057-5","article-title":"Strategies for prevention of transfusion-associated Chagas' disease","volume":"10","author":"Moraes-Souza","year":"1996","journal-title":"Transfus Med Rev"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB84","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1537-2995.1999.39399219290.x","article-title":"Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission","volume":"39","author":"Leiby","year":"1999","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cll.2004.05.009_BIB85","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1537-2995.2002.00077.x","article-title":"Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission","volume":"42","author":"Leiby","year":"2002","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.cll.2004.05.009_BIB86","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/516534","article-title":"Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors","volume":"176","author":"Leiby","year":"1997","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2004.05.009_BIB87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.2003.00279.x","article-title":"An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens","volume":"43","author":"Umezawa","year":"2003","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB88","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/AAC.47.2.475-479.2003","article-title":"Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (Amotosalen HCL) and long-wavelength UV","volume":"47","author":"Van Voorhis","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB89","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0037-86821999000300001","article-title":"Removal of Trypanosoma cruzi by white cell\u2013reduction filters: an electronmicroscopic study","volume":"32","author":"Fabron","year":"1999","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB90","first-page":"495","article-title":"Pathogen reduction technology: methods, status of clinical trials, and future prospects","volume":"2","author":"Corash","year":"2003","journal-title":"Curr Hematol Rep"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2004.05.009_BIB91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1423-0410.2002.tb05315.x","article-title":"Pathogen inactivation: mechanisms of action and in vitro efficacy of various agents","volume":"83","author":"Dodd","year":"2002","journal-title":"Vox Sang"},{"issue":"20","key":"10.1016\/j.cll.2004.05.009_BIB92","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","article-title":"Shattuck lecture\u2014neurodegenerative diseases and prions","volume":"344","author":"Prusiner","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid0302.970208","article-title":"Is Creutzfeldt-Jakob disease transmitted in blood?","volume":"3","author":"Ricketts","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2004.05.009_BIB94","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/tm.2000.7357","article-title":"Variant Creutzfeldt-Jakob disease","volume":"14","author":"Turner","year":"2000","journal-title":"Transfus Med Rev"},{"issue":"5","key":"10.1016\/j.cll.2004.05.009_BIB95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1537-2995.2002.00143.x","article-title":"Animal models of bovine spongiform encephalopathy and vCJD infectivity in blood: two swallows do not a summer make","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2004.05.009_BIB96","unstructured":"US Department of Health and Human Services. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER). Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and variant Creutzfeldt-Jakob Disease (vCJD) by blood and blood products. Available at: http:\/\/www.fda.gov\/cber\/gdlns\/cjdvcjd.htm. Accessed April 9, 2004."},{"key":"10.1016\/j.cll.2004.05.009_BIB97","unstructured":"The UK Creutzfeldt-Jakob Disease Surveillance Unit. Creutzfeldt-Jakob disease surveillance. Available at: http:\/\/www.cjd.ed.ac.uk. Accessed April 9, 2004."},{"issue":"41","key":"10.1016\/j.cll.2004.05.009_BIB98","first-page":"927","article-title":"Probable variant Creutzfeldt-Jakob disease in a US resident\u2014Florida, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9407","key":"10.1016\/j.cll.2004.05.009_BIB99","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cll.2004.05.009_BIB100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1537-2995.2003.t01-1-00351.x","article-title":"Variant CJD transmission through blood: risks to predictors and \u201cpredictees.\u201d","volume":"43","author":"Brown","year":"2003","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.cll.2004.05.009_BIB101","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1537-2995.2003.00392.x","article-title":"The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations","volume":"43","author":"Jackson","year":"2003","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2004.05.009_BIB102","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1423-0410.2002.tb05316.x","article-title":"Pathogen inactivation in cellular blood components: clinical trials and implications of introduction to transfusion medicine","volume":"83","author":"AuBuchon","year":"2002","journal-title":"Vox Sang"},{"key":"10.1016\/j.cll.2004.05.009_BIB103","series-title":"Blood safety in the new millennium","first-page":"79","article-title":"Transfusion safety when you don't know what you are looking for: issues related to emerging pathogens","author":"Kleinman","year":"2001"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1423-0410.1999.7720067.x","article-title":"Oversight and monitoring of blood safety in the United States","volume":"77","author":"Busch","year":"1999","journal-title":"Vox Sang"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2004.05.009_BIB105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1423-0410.2002.tb05270.x","article-title":"Using haemovigilance data to set blood safety priorities","volume":"83","author":"Williamson","year":"2002","journal-title":"Vox Sang"},{"issue":"10","key":"10.1016\/j.cll.2004.05.009_BIB106","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1537-2995.2002.00202.x","article-title":"Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998","volume":"42","author":"Andreu","year":"2002","journal-title":"Transfusion"},{"issue":"Suppl 3","key":"10.1016\/j.cll.2004.05.009_BIB107","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid0703.010331","article-title":"Emerging infectious disease issues in blood safety","volume":"7","author":"Chamberland","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.cll.2004.05.009_BIB108","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-0934(03)00215-5","article-title":"High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan","volume":"112","author":"Mine","year":"2003","journal-title":"J Virol Methods"},{"issue":"1\u20132","key":"10.1016\/j.cll.2004.05.009_BIB109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-0934(03)00194-0","article-title":"Assessment of retroviral activity using a universal retrovirus chip","volume":"112","author":"Seifarth","year":"2003","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.cll.2004.05.009_BIB110","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1371\/journal.pbio.0000002","article-title":"Viral discovery and sequence recovery using DNA microarrays","volume":"1","author":"Wang","year":"2003","journal-title":"PLoS Biol"},{"issue":"7","key":"10.1016\/j.cll.2004.05.009_BIB111","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3201\/eid0907.030004","article-title":"Global screening for human viral pathogens","volume":"9","author":"Anderson","year":"2003","journal-title":"Emerg Infect Dis"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271204000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271204000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T20:42:19Z","timestamp":1586205739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271204000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0272271204000666"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2004.05.009","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}